Tarsus Pharmaceuticals, Inc. TARS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$48.27M+27.3% | -$66.42M+18.2% | -$81.16M+11.8% | -$91.99M+12.3% | -$104.94M+9.2% | ||
| $799K-2.8% | $822K+1.2% | $812K0.0% | $812K+14.0% | $712K+7.6% | ||
| $46.76M+12.1% | $41.72M+19.9% | $34.81M+16.1% | $29.98M+2.6% | $29.23M+5.1% | ||
| —— | —— | —— | -$80.87M-22.7% | -$65.89M+20.6% | ||
| $15.09M+53.0% | $9.86M+176% | $3.57M+83.7% | $1.95M-1.9% | $1.98M+26.5% | ||
| —— | —— | -$150.96M-3.2% | -$146.22M-8.3% | -$135.04M+33.3% | ||
| $8.03M-94.4% | $143.39M-0.4% | $144M+1.4% | $142.08M-22.1% | $182.45M+18.0% | ||
| —— | —— | —— | —— | -$15.36M+88.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tarsus Pharmaceuticals, Inc. generate?
- Tarsus Pharmaceuticals, Inc. (TARS) generated -$96.9M in operating cash flow over the trailing twelve months.
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow?
- After $15.1M of capital expenditures, Tarsus Pharmaceuticals, Inc.'s free cash flow was -$104.4M over the trailing twelve months, down 2.6% year over year.
- Where does Tarsus Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
